Effectiveness of photodynamic therapy in Bowen's disease: An observational and descriptive study in 51 lesions

Journal of the European Academy of Dermatology and Venereology

Volumn 26, Issue 7, 2012, Pages 868-874

  Truchuelo, M ^a   Fernandez Guarino M ^a   Fleta, B ^a   Alcantara J ^a   Jaen P ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; METVIX CREAM; UNCLASSIFIED DRUG;

ADULT; AGED; APPLICATION SITE BURNING; APPLICATION SITE PAIN; ARTICLE; BOWEN DISEASE; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CLINICAL PROTOCOL; DESCRIPTIVE RESEARCH; DRUG EFFICACY; DRUG SAFETY; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; ILLUMINATION; LEG; MALE; OBSERVATIONAL STUDY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RED LIGHT; RETROSPECTIVE STUDY; SKIN BIOPSY; SKIN DEFECT; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGED; AMINOLEVULINIC ACID; BOWEN'S DISEASE; FEMALE; HUMANS; MALE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84862756649     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2011.04175.x     Document Type: Article

References (36)

1. Cox NH, Eedy DJ, Morton CA, Therapy Guidelines and Audit Subcommittee, British Association of Dermatologists. Guidelines for management of Bowen's disease: 2006 update. Br J Dermatol 2007; 156: 11-21.
2. Kessler GM, Ackerman AB,. Nomenclature for very superficial squamous cell carcinoma of the skin and of the cervix: a critique in historical perspective. Am J Dermatopathol 2006; 28: 537-545. (Pubitemid 44813627)
3. Salim A, Leman JA, McColl JH, et al. Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease. Br J Dermatol 2003; 148: 539-543. (Pubitemid 36461334)
4. Calzavara-Pinton PG, Venturini M, et al. Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma. Br J Dermatol 2008; 159: 137-144. (Pubitemid 351874478)
5. Christensen E, Warloe T, Kroon S, et al. Guidelines for practical use of MAL-PDT in non-melanoma skin cancer. J Eur Acad Dermatol Venereol 2010; 24: 505-512.
6. Jaeger AB, Gramkow A, Hjalgrim H,. Bowen disease and risk of subsequent malignant neoplasms: a population-based cohort study of 1147 patients. Arch Dermatol 1999; 135: 790-793. (Pubitemid 29330802)
7. Kossard S, Rosen R,. Cutaneous Bowen's disease. An analysis of 1001 cases according to age, sex, and site. J Am Acad Dermatol 1992; 27: 406-410.
8. Kovacs A, Yonemoto K, Katsuoka K, et al. Bowen's disease: statistical study of a 10 year period. J Dermatol 1996; 23: 267-274. (Pubitemid 26165748)
9. Morton C, Horn M, Leman J, et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: results of a multicenter randomized trial. Arch Dermatol 2006; 142: 729-735.
10. Morton CA, Whitehurst C, Moseley H, et al. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br J Dermatol 1996; 135: 766-771. (Pubitemid 26375895)
11. Leibovitch I, Huilgol SC, Selva D, et al. Cutaneous squamous carcinoma in situ (Bowen's disease): treatment with Mohs micrographic surgery. J Am Acad Dermatol 2005; 52: 997-1002. (Pubitemid 40732538)
12. Varma S, Holt PJ, Anstey AV,. Erythroplasia of Queyrat treated by topical aminolaevulinic acid photodynamic therapy: a cautionary tale. Br J Dermatol 2000; 142: 825-826. (Pubitemid 30226411)
13. Stables GI, Stringer MR, Robinson DJ, et al. Erythroplasia of Queyrat treated by topical aminolaevulinic acid photodynamic therapy. Br J Dermatol 1999; 140: 514-517. (Pubitemid 29182888)
14. Aguilar M, de Troya M, Martin L, et al. A cost analysis of photodynamic therapy with methyl aminolevulinate and imiquimod compared with conventional surgery for the treatment of superficial basal cell carcinoma and Bowen's disease of the lower extremities. J Eur Acad Dermatol Venereol 2010; 24: 1431-1436.
15. Ramrakha-Jones VS, Herd RM,. Treating Bowen's disease: a cost-minimization study. Br J Dermatol 2003; 148: 1167-1172. (Pubitemid 36819216)
16. Lehmann P,. Methyl aminolaevulinate-photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer. Br J Dermatol 2007; 156: 793-801. (Pubitemid 46642865)
17. Patel GK, Goodwin R, Chawla M, et al. Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen's disease): a randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol 2006; 54: 1025-1032.
18. Varma S, Wilson H, Kurwa HA, et al. Bowen's disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source. Br J Dermatol 2001; 144: 567-574. (Pubitemid 32232013)
19. Dijkstra AT, Majoie IM, van Dongen JW, et al. Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma. J Eur Acad Dermatol Venereol 2001; 15: 550-554. (Pubitemid 34041188)
20. Stables GI, Stringer MR, Robinson DJ, et al. Large patches of Bowen's disease treated by topical aminolaevulinic acid photodynamic therapy. Br J Dermatol 1997; 136: 957-960. (Pubitemid 27283535)
21. Morton CA, Whitehurst C, McColl JH, et al. Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma. Arch Dermatol 2001; 137: 319-324. (Pubitemid 32240786)
22. Drake AL, Walling HW,. Variations in presentation of squamous cell carcinoma in situ (Bowen's disease) in immunocompromised patients. J Am Acad Dermatol 2008; 59: 68-71.
23. Morton CA,. Methyl aminolevulinate: actinic keratoses and Bowen's disease. Dermatol Clin 2007; 25: 81-87. (Pubitemid 44780063)
24. Morton CA, Brown SB, Collins S, et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 2002; 146: 552-567. (Pubitemid 34437765)
25. Morton CA, Whitehurst C, Moore JV, et al. Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy. Br J Dermatol 2000; 143: 767-772.
26. Alexiades-Armenakas M,. Laser-mediated photodynamic therapy. Clin Dermatol 2006; 24: 16-25. (Pubitemid 43112351)
27. Britton JE, Goulden V, Stables G, et al. Investigation of the use of the pulsed dye laser in the treatment of Bowen's disease using 5-aminolaevulinic acid phototherapy. Br J Dermatol 2005; 153: 780-784. (Pubitemid 41415905)
28. Tyrell JS, Morton CA, Campbell SM, et al. Comparison of PpIX accumulation and destruction during methyl-aminolevulinate photodynamic therapy (MAL-PDT) of skin tumours located at acral and non-acral sites. Br J Dermatol 2011; 8: 30-38.
29. Ortega-Bravo M, Casanova-Seuma JM,. Prevalencia del Cáncer cutáneo no melanoma y factores de riesgo asociados. Tesis. Facultad de Medicina de Lleida, Spain, 2003.
30. Marcil I, Stern R,. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer. A critical review of the literature and meta-analysis. Arch Dermatol 2000; 136: 1524-1530. (Pubitemid 32009273)
31. Strauss R, Fazio V,. Bowen's disease of the anal and perianal area: a report and analysis of twelve cases. Am J Surg 1979; 137: 231-234. (Pubitemid 9092119)
32. Margoob AA, Kopf AW, Bart RS, et al. Risk of another basal cell carcinoma developing after treatment of a basal cell carcinoma. J Am Acad Dermatol 1993; 28: 22.
33. Szeimies RM, Landthaler M,. Photodynamic therapy and fluorescence diagnosis of skin cancers. Recent Results Cancer Res 2002; 160: 240-245.
34. Fernandez-Guarino M, Harto A, Sanchez-Ronco M, Perez-Garcia B, Marquet A, Jaen P,. Retrospective, descriptive, observational study of treatment of multiple actinic keratoses with topical methyl aminolevulinate and red light: results in clinical practice and correlation with fluorescence imaging. Actas Dermosifiliogr 2008; 99: 779-787.
35. Harto AL, Fernández M,. EDUCACION MEDICA CONTINUA: diagnõstico por fluorescencia o fotodinámico. Fotografía con luz ultravioleta. Rev Chilena Dermatol 2007; 14: 30-35.
36. Sanclemente G, Medina L, Villa JF, et al. A prospective split-face double-blind randomized placebo-controlled trial to assess the efficacy of methyl aminolevulinate + red-light in patients with facial photodamage. J Eur Acad Dermatol Venereol 2011; 25: 49-58.